BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19225920)

  • 1. Current status and perspectives of brachytherapy for cervical cancer.
    Toita T
    Int J Clin Oncol; 2009 Feb; 14(1):25-30. PubMed ID: 19225920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
    Wang X; Liu R; Ma B; Yang K; Tian J; Jiang L; Bai ZG; Hao XY; Wang J; Li J; Sun SL; Yin H
    Cochrane Database Syst Rev; 2010 Jul; (7):CD007563. PubMed ID: 20614461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
    Liu R; Wang X; Tian JH; Yang K; Wang J; Jiang L; Hao XY
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD007563. PubMed ID: 25300170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule.
    Toita T; Kakinohana Y; Ogawa K; Adachi G; Moromizato H; Nagai Y; Maehama T; Sakumoto K; Kanazawa K; Murayama S
    Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1344-53. PubMed ID: 12873679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose-rate vs. low-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix: Systematic review and meta-analysis.
    Lee KK; Lee JY; Nam JM; Kim CB; Park KR
    Brachytherapy; 2015; 14(4):449-57. PubMed ID: 25906951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: efficacy and toxicity of a low cumulative radiation dose schedule.
    Toita T; Kitagawa R; Hamano T; Umayahara K; Hirashima Y; Aoki Y; Oguchi M; Mikami M; Takizawa K;
    Gynecol Oncol; 2012 Aug; 126(2):211-6. PubMed ID: 22555110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer.
    Toita T; Moromizato H; Ogawa K; Kakinohana Y; Maehama T; Kanazawa K; Murayama S
    Gynecol Oncol; 2005 Mar; 96(3):665-70. PubMed ID: 15721409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National survey of intracavitary brachytherapy for intact uterine cervical cancer in Japan.
    Toita T; Ohno T; Ikushima H; Nishimura T; Uno T; Ogawa K; Onishi H; Dokiya T; Itami J;
    J Radiat Res; 2018 Jul; 59(4):469-476. PubMed ID: 29986113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
    Toita T; Kato S; Niibe Y; Ohno T; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Tokumaru S; Yamauchi C; Suzuki O; Sakurai H; Numasaki H; Teshima T; Oguchi M; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e49-56. PubMed ID: 21470794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results for Stage IIIB cervical cancer patients receiving external beam radiotherapy combined with either HDR (252)Cf or HDR (60)Co intracavitary brachytherapy.
    Ulinskas K; Janulionis E; Valuckas KP; Samerdokiene V; Atkocius V; Rivard MJ
    Brachytherapy; 2016; 15(3):353-360. PubMed ID: 26996594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective cohort study to compare treatment results between 2 fractionation schedules of high-dose-rate intracavitary brachytherapy (HDR-ICBT) in patients with cervical cancer.
    Huang EY; Sun LM; Lin H; Lan JH; Chanchien CC; Huang YJ; Wang CY; Wang CJ
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):123-8. PubMed ID: 22672751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of radiotherapy practice for patients with cervical cancer (1999-2001): patterns of care study in Japan.
    Toita T; Kodaira T; Shinoda A; Uno T; Akino Y; Mitsumori M; Teshima T
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):788-94. PubMed ID: 18191331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Outcomes of Computed Tomography-Based Volumetric Brachytherapy Planning for Cervical Cancer.
    Simpson DR; Scanderbeg DJ; Carmona R; McMurtrie RM; Einck J; Mell LK; McHale MT; Saenz CC; Plaxe SC; Harrison T; Mundt AJ; Yashar CM
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):150-7. PubMed ID: 26130230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locally advanced cervical cancer: how the improvement in techniques in external beam radiotherapy and brachytherapy impacts on survival outcomes and long-term toxicities.
    Barbera F; Frassine F; Volpi G; Ghedi B; Pasinetti N
    Radiol Med; 2023 Dec; 128(12):1542-1552. PubMed ID: 37640897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix.
    Nakano T; Kato S; Ohno T; Tsujii H; Sato S; Fukuhisa K; Arai T
    Cancer; 2005 Jan; 103(1):92-101. PubMed ID: 15540233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-volume parameters and local tumor control in cervical cancer treated with central-shielding external-beam radiotherapy and CT-based image-guided brachytherapy.
    Okazaki S; Murata K; Noda SE; Kumazaki Y; Hirai R; Igari M; Abe T; Komatsu S; Nakano T; Kato S
    J Radiat Res; 2019 Jul; 60(4):490-500. PubMed ID: 31111896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy for uterine cervical cancer: results of the 1995-1997 patterns of care process survey in Japan.
    Toita T; Nakamura K; Uno T; Kodaira T; Shinoda A; Ogawa K; Mitsuhashi N; Maebayashi K; Kawaguchi A; Inoue T; Teshima T
    Jpn J Clin Oncol; 2005 Mar; 35(3):139-48. PubMed ID: 15741304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience.
    Petereit DG; Sarkaria JN; Potter DM; Schink JC
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1267-74. PubMed ID: 10613322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current controversies in high-dose-rate versus low-dose-rate brachytherapy for cervical cancer.
    Stewart AJ; Viswanathan AN
    Cancer; 2006 Sep; 107(5):908-15. PubMed ID: 16874815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
    Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.